AQST Operating Cash Flow Growth

Aquestive Therapeutics Inc · Operating Cash Flow Growth

AQST logo

AQST Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported8.69%
AQST TTM Cash from Operations YoY % (-323.06% → 8.69%)
High-resolution chart · PNG

AQST operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
8.6911%
10.122%
-46.626%
-47.4687%
-101.3169%
-90.6763%
-460.4859%
-588.1849%
-302.8856%
-289.3552%
34.8248%
126.6504%
131.868%
140.4897%
70.3175%
31.5743%
-1.3058%
27.3416%
27.4533%
9.6233%
23.103%
18.2456%
24.4993%
18.9239%
0.2748%
-78.5573%
-363.4747%
-198.1976%
-616.4284%
-1,264.6057%
-323.0598%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.